EBOS Group Limited (EBOS) has announced the successful completion of a NZ$674 million / A$642 million placement of approximately 19.5 million new fully paid ordinary shares, to partly fund the acquisition of LifeHealthcare.
The Placement was strongly supported by existing and new investors, with Eligible shareholders allocated their full bid on a best endeavours basis.
The Retail Offer Booklet will be released to the NZX and ASX, and sent to eligible shareholders on or about Wednesday, 15 December 2021, with the closing date for applications by eligible shareholders being Monday, 17 January 2022.
EBOS’ ordinary shares will recommence trading upon market open today, with settlement of the Placement expected to occur on Tuesday, 14 December and Wednesday, 15 December for the ASX and NZX respectively.
See more
